FDA Inspection 1234656 — Alejandra M. Villamil, M.D.
The FDA completed an inspection of Alejandra M. Villamil, M.D. on Mar 22, 2024 in Ciudad Autonoma Buenos Aires. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 22, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ciudad Autonoma Buenos Aires (Argentina)
Additional details
Clinical Investigator (CI)